Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 49
- Press releases
Apollon Formularies Announces Acquisition Of Citiva Jamaica LLC & Collaboration Agreement With University Of West Indies
APOLLON Formularies plc (AQSE: APOL, “Apollon” or the “Company”), a UK-based international pharmaceutical company trading on the Aquis Stock Exchange, is delighted to announce that its Jamaican affiliate, Apollon Formularies Jamaica Ltd (“Apollon Jamaica“), has reached an agreement to acquire Citiva Jamaica LLC (“Citiva Jamaica“) (the “Acquisition“) in a part-cash, part-shares transaction.
- Cultivation
Apollon to acquire world-class research and production facility in Jamaica
Apollon has reached an agreement to acquire Citiva Jamaica in a part-cash, part-shares transaction.
- Companies
MGC Pharma sees progress across clinical pipelines
The company has provided an update on its activities.
- Medical
Call for sponsors for UK’s first medical cannabis patient conference
The UK’s first medical cannabis patient conference will take place in November.
- Adult-Use
Schumer commits to making some progress on cannabis this year
BIPARTISAN BILL Schumer commits to making some progress on cannabis this year Senate Majority Leader Chuck Schumer has pledged to get “something” achieved on the cannabis reform file “this year” by taking a bipartisan approach, per Marijuana Moment.
- Companies
UK education platform to teach Mauritius doctors about medical cannabis
Sativa Learning will be providing education as the country explores a medical cannabis programme.
- Pharmaceutical
European Cannabis Stocks Review: IM Cannabis Could Be Delisted From NASDAQ, DeepVerge Jumps 40%, & More From OCT & Ananda Developments
IM Cannabis IM Cannabis announced to investors earlier this week that on Wednesday, July 13, it was warned its stocks could soon be removed from the NASDAQ stock exchange unless its stock price rises above $1.
- Medical
Schumer’s cannabis bill unlikely to pass, but will ‘shape the conversation’
CAOA INTRODUCED Schumer’s cannabis bill unlikely to pass, but will ‘shape the conversation’ Senate Majority Leader Chuck Schumer’s federal cannabis bill, the Cannabis Administration and Opportunity Act (CAOA), was finally introduced yesterday morning, reports Politico.
- Medical
Clever Leaves announces first export of cannabis flower to Israel
Clever Leaves has officially entered into Israel’s flower market with the first commercial high-quality THC flower export from its cultivation facility in Portugal.
- Companies
Gerardo Gorostiza joins team at Linneo Health
Linneo Health has appointed Gorostiza as chief financial and strategy officer.
- Cultivation
Ananda completes first step in genetic stabilisation programme
The AQSE Growth Market listed company has now begun the self-crossing of the first generation of cannabis plants.
- Adult-Use
Broughton expands experience from nicotine into cannabinoids
Broughton CEO Chris Allen spoke to Cannabis Wealth about the company’s ambitions to support safe and effective cannabinoid delivery.
